FIELD: medicine, oncology, peptides.
SUBSTANCE: invention describes a method for reducing or inhibition of proliferation of oncogenic cells by using growth hormone-release compound or its antagonist that are able to replace radioactive marker 125J-Tyr-Ala-His-D-Mrp-Ala-Trp-D-Phe-Lys-NH2 from tumor tissue. Tumors can represent lung, breast, thyroid or pancreas tumors. The preferable compounds represent peptides that comprise residues of methyltryptophan and lysine.
EFFECT: improved inhibition method, valuable antitumor properties of compound.
13 cl
Authors
Dates
2004-11-20—Published
1999-11-11—Filed